Werewolf Therapeutics Selected for Oral Presentation at SITC 2026
Werewolf Therapeutics says it was selected for an oral presentation and will present posters at the Society for Immunotherapy of Cancer’s 2026 annual meeting.
Werewolf Therapeutics says it was selected for an oral presentation and will present posters at the Society for Immunotherapy of Cancer’s 2026 annual meeting.